TC BioPharm Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Lease liabilities and similar (Tables)

12 Months Ended

Dec. 31, 2022

Maturity analysis of leases and similar

Schedule of maturity analysis

December 31, 2022	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		495,482		167,449		328,033
Between one year and five years		1,788,060		400,029		1,388,031
More than five years		446,766		22,347		424,419
Lease Liabilities		2,730,308		589,825		2,140,483

December 31, 2021	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		1,010,039		244,281		765,758
Between one year and five years		1,849,762		525,317		1,324,445
More than five years		893,077		80,647		812,430
Lease Liabilities		3,752,878		850,245		2,902,633

TC BIOPHARM (HOLDINGS) PLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

17. Lease liabilities and similar (continued)

The balances relating to lease liabilities and similar can be further analyzed as follows:

Lease liabilities

Schedule of maturity analysis

December 31, 2022	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		451,029		166,069		284,960
Between one year and five years		1,788,060		400,029		1,388,031
More than five years		446,766		22,347		424,419
Lease Liabilities		2,685,855		588,445		2,097,410

December 31, 2021	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		768,839		227,630		541,209
Between one year and five years		1,793,412		523,560		1,269,852
More than five years		893,077		80,647		812,430
Lease Liabilities		3,455,328		831,837		2,623,491

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

	Buildings £			Other £			Total £
At January 1, 2021	1,571,829			10,271			1,582,100
Charge for the year		(192,469	)		(4,107	)		(196,576	)
At December 31, 2021		1,379,360			6,164			1,385,524

At January 1, 2022		1,379,360			6,164			1,385,524
Right-of-use assets, beginning balance		1,379,360			6,164			1,385,524
Charge for the year		(192,469	)		(4,108	)		(196,577	)
At December 31, 2022		1,186,891			2,056			1,188,947
Right-of-use assets, ending balance		1,186,891			2,056			1,188,947

The following amounts are recognized in the consolidated statements of comprehensive loss:

	Year ended December 31,		Year ended December 31,
	2022		2021
	£		£
Amortization of right of use assets		196,577		196,576
Interest on lease liabilities		260,206		254,653
Total		456,783		451,229

Schedule of maturity analysis

December 31, 2022	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		44,452		1,380		43,073
Between one year and five years		-		-		-
Lease Liabilities		44,452		1,380		43,073

December 31, 2021	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		241,200		16,651		224,549
Between one year and five years		56,350		1,757		54,593
Lease Liabilities		297,550		18,408		279,142

December 31, 2022	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		451,029		166,069		284,960
Between one year and five years		1,788,060		400,029		1,388,031
More than five years		446,766		22,347		424,419
Lease Liabilities		2,685,855		588,445		2,097,410

December 31, 2021	Undiscounted lease payments		Interest		Present value
	£		£		£
Not later than one year		768,839		227,630		541,209
Between one year and five years		1,793,412		523,560		1,269,852
More than five years		893,077		80,647		812,430
Lease Liabilities		3,455,328		831,837		2,623,491